HECTD2 and neoplasm: However, the much larger number of ‘HECTD2’-expressing samples without evidence of an anti-tumour T cell response, suggests either lack of inherent immunogenicity of these tumours or, alternatively, active HECTD2-mediated immune modulation, only a small part of which could be attributed to the immune suppressive ‘COX’ module.